Evans Terry L (CIK 2043317) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-31). Recent activity: Buy FENC (168 shares), Buy FENC (168 shares), Buy FENC (168 shares), Buy FENC (168 shares), Buy FENC (168 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-31 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Commercial Officer | Buy | 168 | $0 |
| 2026-08-03 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Commercial Officer | Buy | 168 | $0 |
| 2026-07-01 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Commercial Officer | Buy | 168 | $0 |
| 2026-06-01 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Commercial Officer | Buy | 168 | $0 |
| 2026-05-01 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Commercial Officer | Buy | 168 | $0 |
| 2026-04-02 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Commercial Officer | Buy | 18,456 | $0 |
| 2026-04-02 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Commercial Officer | Buy | 171 | $0 |
| 2026-04-02 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Commercial Officer | Buy | 2,052 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-31